sham remote ischemic preconditioning
sham remote ischemic preconditioning is a medical device with 9 clinical trials. Currently 1 active trials ongoing. Historical success rate of 83.3%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
83.3%
5 of 6 finished
16.7%
1 ended early
1
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effect of Remote Ischemic Preconditioning on Early Neurological Deterioration in Acute Perforating Artery Infarction
Remote Ischemic Preconditioning in Cardiac Surgery
Remote Ischemic Preconditioning and Contrast Induced - Acute Kidney Injury in Patients Undergoing Elective PCI
The Saint Francis Remote Ischemic Preconditioning Trial (SaFR)
Effects of Remote Ischemic Pre-Conditioning in Moyamoya Disease Patients
Clinical Trials (9)
Effect of Remote Ischemic Preconditioning on Early Neurological Deterioration in Acute Perforating Artery Infarction
Remote Ischemic Preconditioning in Cardiac Surgery
Remote Ischemic Preconditioning and Contrast Induced - Acute Kidney Injury in Patients Undergoing Elective PCI
The Saint Francis Remote Ischemic Preconditioning Trial (SaFR)
Effects of Remote Ischemic Pre-Conditioning in Moyamoya Disease Patients
Remote Ischemic Preconditioning as a Method Against Subclinical Renal Injury and Contrast-induced Nephropathy
Protective Effects of Long-term Remote Limb Ischemic Preconditioning For Carotid Artery Stenting
Clinical Trial on Remote Ischemic Preconditioning and Cerebral Small Vessel Disease
Efficacy of RIPC to Reduce AKI for Patients Undergoing PCI
All 9 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 9